B

Active Director Director DIN 10918991
DIN 10918991 First appointment Feb 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Bimla

Data last updated:

Bimla is a Director at Transcis Ai Private Limited (since 2025) and Director at Igenomics Solutions Private Limited (since 2025). The companies operate in Healthcare.

DIN 10918991
Primary Designation Director
Industry Healthcare
First Appointment 05 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Transcis Ai Private Limited U46596UP2025PTC220735
Director07 Apr 20252025Active
Igenomics Solutions Private Limited U86905MH2025PTC439647
Director05 Feb 20252025Active

Board colleagues of Bimla

Directorship timeline

Open interactive timeline →
Transcis Ai Private Limited
Igenomics Solutions Private Limited
Premium access

Shareholding and investment profile for Bimla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bimla

Bimla currently holds 2 directorships: Transcis Ai Private Limited (Director, since 07 Apr 2025); Igenomics Solutions Private Limited (Director, since 05 Feb 2025).

Bimla was first appointed on 05 Feb 2025 as Director at Igenomics Solutions Private Limited.

The current boards of Bimla's companies include Venkata Chalapathirao Gurramkonda (Transcis Ai Private Limited), Prakash Girdhari Dhirwani (Igenomics Solutions Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available